Up-regulation of miR-582-5p regulates cellular proliferation of prostate cancer cells under androgen-deprived conditions

Prostate

Volumn 74, Issue 16, 2014, Pages 1604-1612

  Maeno, Atsushi ^a   Terada, Naoki ^a   Uegaki, Masayuki ^a   Goto, Takayuki ^a   Okada, Yoshiyuki ^a   Kobayashi, Takashi ^a   Kamba, Tomomi ^a   Ogawa, Osamu ^a   Inoue, Takahiro ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

castration resistant; EFNB2; miR 582 5p; prostate cancer

Indexed keywords

EPHRIN B2; MICRORNA; MIR 582 5P; UNCLASSIFIED DRUG; ANDROGEN; MIRN582 MICRORNA, HUMAN;

ARTICLE; CANCER CELL; CANCER GROWTH; CARCINOGENESIS; CASTRATION RESISTANT PROSTATE CANCER; CELL COUNTING; CELL PROLIFERATION; CONTROLLED STUDY; LNCAP CELL LINE; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TUMOR XENOGRAFT; UPREGULATION; ADENOCARCINOMA; ANIMAL; CASTRATION; CELL CYCLE; CELL CYCLE S PHASE; DEFICIENCY; HUMAN; MALE; MOUSE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROSTATE TUMOR; TUMOR CELL LINE; XENOGRAFT;

ADENOCARCINOMA; ANDROGENS; ANIMALS; CASTRATION; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; HETEROGRAFTS; HUMANS; MALE; MICE; MICROARRAY ANALYSIS; MICRORNAS; PROSTATIC NEOPLASMS; S PHASE; UP-REGULATION;

EID: 84921988645     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.22877     Document Type: Article

References (27)

1. Calin GA, Croce CM,. MicroRNA signatures in human cancers. Nat Rev Cancer 2006; 6: 857-866.
2. Esquela-Kerscher A, Slack FJ,. Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer 2006; 6: 259-269.
3. Dalmay T, Edwards DR,. MicroRNAs and the hallmarks of cancer. Oncogene 2006; 25 (46): 6170-6175.
4. Porkka KP, Pfeiffer MJ, Waltering KK, Vessella RL, Tammela TL, Visakorpi T,. MicroRNA expression profiling in prostate cancer. Cancer Res 2007; 67: 6130-6135.
5. Ribas J, Ni X, Haffner M, Wentzel EA, Salmasi AH, Chowdhury WH, Kudrolli TA, Yegnasubramanian S, Luo J, Rodriguez R, Mendell JT, Lupold SE,. miR-21: An androgen receptor-regulated microRNA that promotes hormone-dependent and hormone-independent prostate cancer growth. Cancer Res 2009; 69: 7165-7169.
6. Ma S, Chan YP, Kwan PS, Lee TK, Yan M, Tang KH, Ling MT, Vielkind JR, Guan XY, Chan KW,. MicroRNA-616 induces androgen-independent growth of prostate cancer cells by suppressing expression of tissue factor pathway inhibitor TFPI-2. Cancer Res 2011; 71 (2): 583-592.
7. Inoue T, Kobayashi T, Terada N, Shimizu Y, Kamoto T, Ogawa O, Nakamura E,. Roles of androgen-dependent and -independent activation of signal transduction pathways for cell proliferation of prostate cancer cells. Expert Rev Endocrinol Metab 2007; 2: 689-704.
8. Terada N, Shimizu Y, Kamba T, Inoue T, Maeno A, Kobayashi T, Nakamura E, Kamoto T, Kanaji T, Maruyama T, Mikami Y, Toda Y, Matsuoka T, Okuno Y, Tsujimoto G, Narumiya S, Ogawa O,. Identification of EP4 as a potential target for the treatment of castration-resistant prostate cancer using a novel xenograft model. Cancer Res 2010; 70 (4): 1606-1615.
9. Inoue T, Yoshida T, Shimizu Y, Kobayashi T, Yamasaki T, Toda Y, Segawa T, Kamoto T, Nakamura E, Ogawa O,. Requirement of androgen-dependent activation of protein kinase Cζfor androgen-dependent cell proliferation in LNCaP Cells and its roles in transition to androgen-independent cells. Mol Endocrinol 2006; 20: 3053-3069.
10. Ameya D, Jessica C, Angelica L,. How to choose a normalization strategy for miRNA quantitative real-time (qPCR) arrays. J Bioinfo and Compu Bio 2011; 9: 795-812.
11. Tomlins SA, Mehra R, Rhodes DR, Cao X, Wang L, Dhanasekaran SM, Kalyana-Sundaram S, Wei JT, Rubin MA, Pienta KJ, Shah RB, Chinnaiyan AM,. Integrative molecular concept modeling of prostate cancer progression. Nat Genet 2007; 39 (1): 41-51.
12. Wu Z, He B, He J, Mao X,. Upregulation of miR-153 promotes cell proliferation via downregulation of the PTEN tumor suppressor gene in human prostate cancer. Prostate 2013; 73 (6): 596-604.
13. Sun T, Wang Q, Balk S, Brown M, Lee GS, Kantoff P,. The role of microRNA-221 and microRNA-222 in androgen-independent prostate cancer cell lines. Cancer Res 2009; 69 (8): 3356-3363.
14. Shi XB, Xue L, Yang J, Ma AH, Zhao J, Xu M, Tepper CG, Evans CP, Kung HJ, deVere White RW,. An androgen-regulated miRNA suppresses Bak1 expression and induces androgen-independent growth ofprostate cancer cells. Proc Natl Acad Sci U S A 2007; 104 (50): 19983-19988.
15. Qu F, Cui X, Hong Y, Wang J, Li Y, Chen L, Liu Y, Gao Y, Xu D, Wang Q,. MicroRNA-185 suppresses proliferation, invasion, migration, and tumorigenicity of human prostate cancer cells through targeting androgen receptor. Mol Cell Biochem 2013; 377 (1-2): 121-130.
16. Uzoh CC, Holly JM, Biernacka KM, Persad RA, Bahl A, Gillatt D, Perks CM,. Insulin-like growth factor-binding protein-2 promotes prostate cancer cell growth via IGF-dependent or -independent mechanisms and reduces the efficacy of docetaxel. Br J Cancer 2011; 104 (10): 1587-1593.
17. Uchino K, Takeshita F, Takahashi RU, Kosaka N, Fujiwara K, Naruoka H, Sonoke S, Yano J, Sasaki H, Nozawa S, Yoshiike M, Kitajima K, Chikaraishi T, Ochiya T,. Therapeutic effects of microRNA-582-5p and -3p on the inhibition of bladder cancer progression. Mol Ther 2013; 21 (3): 610-619.
18. Lu YC, Chen YJ, Wang HM, Tsai CY, Chen WH, Huang YC, Fan KH, Tsai CN, Huang SF, Kang CJ, Chang JT, Cheng AJ,. Oncogenic function and early detection potential of miRNA-10b in oral cancer as identified by microRNA profiling. Cancer Prev Res (Phila) 2012; 5 (4): 665-674.
19. Amir S, Ma AH, Shi XB, Xue L, Kung HJ, Devere White RW,. Oncomir miR-125b suppresses p14(ARF) to modulate p53-dependent and p53-independent apoptosis in prostate cancer. PLoS One 2013; 8 (4): e61064.
20. Feliciano A, Castellvi J, Artero-Castro A, Leal JA, Romagosa C, Hernández-Losa J, Peg V, Fabra A, Vidal F, Kondoh H, Ramõn Y, Cajal S, Lleonart ME,. miR-125b Acts as a Tumor Suppressor in Breast Tumorigenesis via Its Novel Direct Targets ENPEP, CK2-α, CCNJ, and MEGF9. PLoS One 2013; 8 (10): e76247.
21. Haflidadõttir BS, Larne O, Martin M, Persson M, Edsjö A, Bjartell A, Ceder Y,. Upregulation of miR-96 enhances cellular proliferation of prostate cancer cells through FOXO1. PLoS One 2013; 8 (8): e72400.
22. Vishwamitra D, Li Y, Wilson D, Manshouri R, Curry CV, Shi B, Tang XM, Sheehan AM, Wistuba II, Shi P, Amin HM,. MicroRNA 96 is a post-transcriptional suppressor of anaplastic lymphoma kinase expression. Am J Pathol 2012; 180 (5): 1772-1780.
23. Wang Q, Li W, Zhang Y, Yuan X, Xu K, Yu J, Chen Z, Beroukhim R, Wang H, Lupien M, Wu T, Regan MM, Meyer CA, Carroll JS, Manrai AK, Jänne OA, Balk SP, Mehra R, Han B, Chinnaiyan AM, Rubin MA, True L, Fiorentino M, Fiore C, Loda M, Kantoff PW, Liu XS, Brown M,. Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer. Cell 2009; 138: 245-256.
24. Feldman BJ, Feldman D,. The development of androgen-independent prostate cancer. Nat Rev Cancer 2001; 1: 34-45.
25. Kataoka H, Tanaka M, Kanamori M, Yoshii S, Ihara M, Wang YJ, Song JP, Li ZY, Arai H, Otsuki Y, Kobayashi T, Konno H, Hanai H, Sugimura H,. Expression profiles of EFNB1, EFNB2, two ligands of EPHB2 in human gastric cancer. J Cancer Res clin Oncol 2002; 128: 343-348.
26. Rutkowski R, Mertens-Walker I, Lisle JE, Herington AC, Stephenson SA,. Evidence for a dual function of EphB4 as tumor promoter and suppressor regulated by the absence or presence of the ephrin-B2 ligand. Int J Cancer 2012; 131 (5): E614-E624.
27. Noren NK, Lu M, Freeman AL, Koolpe M, Pasquale EB,. Interplay between EphB4 on tumor cells and vascular ephrin-B2 regulates tumor growth. Proc Natl Acad Sci U S A 2004; 101 (15): 5583-5588.